FindTrial
Sign In

Autologous HSCT

PROCEDURE5 trials

Sponsors

National Research Center for Hematology, Russia, European Society for Blood and Marrow Transplantation, Swedish Medical Center

Conditions

Autoimmune DiseasesDiffuse Large B Cell LymphomaPh-negative Adult Acute Lymphoblastic LeukemiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Phase 2

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
NCT03736616
Swedish Medical CenterDiffuse Large B Cell Lymphoma
Start: 2019-08-16End: 2023-09-30Target: 47Updated: 2022-07-22

Unknown Phase

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment
NCT01193933
National Research Center for Hematology, RussiaPh-negative Adult Acute Lymphoblastic Leukemia
Start: 2008-11-30End: 2021-12-31Target: 321Updated: 2018-03-07
EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients
CompletedNCT02516124
European Society for Blood and Marrow TransplantationAutoimmune Diseases
Start: 2012-12-31End: 2018-03-31Updated: 2018-05-01
EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)
NCT03444805
European Society for Blood and Marrow TransplantationAutoimmune Diseases
Start: 2019-07-01End: 2023-03-30Target: 60Updated: 2019-09-03
De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)
NCT03462095
National Research Center for Hematology, RussiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Start: 2017-01-31End: 2022-12-01Target: 350Updated: 2018-03-13

Related Papers

The significance of CD20 expression in adult patients with <i>BCR::ABL1</i>-negative acute B-cell lymphoblastic leukemia treated according to RALL-2016 protocol
Oncohematology2025-12-10
Updated Response and Safety for Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Blood2024-11-051 citations
P396: FIFTEEN YEARS OF RUSSIAN RESEARCH IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE PH-NEGATIVE LYMPHOBLASTIC LEUKEMIA ACCORDING TO THE PROTOCOLS ALL-2009 AND ALL-2016.
HemaSphere2023-08-01
Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial
Oncohematology2023-03-133 citations
Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia
Diagnostics2022-12-214 citations
Polymorphisms of the <i>TPMT</i>, <i>NUDT15</i> genes and 6-mercaptopurine toxicity profile in adult patients with Ph-negative acute lymphoblastic leukemia/lymphomas on the ALL-2016 protocol
Oncohematology2022-07-20
Initial Safety Results from a Phase II Study of Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Blood2021-11-05
Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Blood2020-11-051 citations
Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease
Blood2020-11-05
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party
Haematologica2020-01-16106 citations
Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients
Blood2019-11-13
Лечение острых лим-фобластных лейкозов у беременных по протоколу ОЛЛ-2009
2019-06-21
MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL
Blood2018-11-29
Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia
Terapevticheskii arkhiv2018-07-155 citations
The Frequency and Impact of IKZF1 Deletions on Minimal Residual Disease in Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Patients Treated in Russian Acute Lymphoblastic Leukemia Study
Blood2017-12-07
CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009
Oncohematology2017-10-253 citations
[Adult B-cell acute lymphoblastic leukemias: Conclusions of the Russian prospective multicenter study ALL-2009].
2017-01-01
The Different Treatment Approaches in Younger Patients with Angioimmunoblastic T-Cell Lymphoma
Blood2016-12-02
No Differences in the Treatment Outcome in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Regarding the Initial Bone Marrow Blasts Count: Results of the Russian Acute Lymphoblastic Leukemia (RALL) Study Group
Blood2016-12-02
De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors
Blood2016-12-02

2 more papers not shown